Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

145.65 -0.30 (-0.21%)
Official Closing Price Updated: 4:10 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
96 97 Next >
The Top 7 Dividend Stocks to Buy in March 2024
Bet on these top dividend stocks to buy for a resilient income flow and steady market gains, offering excellent balance. 
Via InvestorPlace
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
As President Biden prepares for his State of the Union address, he will address issues such as Bidenomics, healthcare, and the US's role in the world. 
Via Benzinga
7 No-Frills Dividend Stocks for Your Must-Own List
Income investors don't need to invest in risky businesses when no-frills dividend stocks get the job done just fine. 
Via InvestorPlace
Smart Money Is Betting Big In JNJ Options
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Beyond The Numbers: 13 Analysts Discuss Johnson & Johnson Stock
Via Benzinga
Evaluating Johnson &amp; Johnson Against Peers In Pharmaceuticals Industry
Via Benzinga
Is NYSE:JNJ suited for dividend investing?
Balancing Dividends and Fundamentals: The Case of JOHNSON & JOHNSON (NYSE:JNJ). 
Via Chartmill
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
Here are seven dividend kings that manage to deliver market-beating stock price growth in addition to their reliable, growing dividends. 
Via InvestorPlace
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2030?
Can Johnson & Johnson stock become a hot buy for growth-focused investors, or is this mainly just a dividend play? 
Via The Motley Fool
Johnson & Johnson Jump?
Johnson and Johnson is coming into a strong seasonal pattern now with an average return of nearly 5%. 
Via Talk Markets
Don’t Panic! 7 Smart Stocks to Buy if the Markets Take a Tumble.
No one wants the red ink to start flying right now. However, if it does, these are the stocks to buy for a down market. 
Via InvestorPlace
Want $1,000 in Ultra-Safe Annual Dividend Income? Invest $19,000 Into the Following 3 Time-Tested Dividend Kings.
These rock-solid dividend stocks, which sport an average yield of 5.26%, have raised their base annual payouts for between 54 and 62 consecutive years. 
Via The Motley Fool
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
Johnson & Johnson Stock Has 33% Upside, According to 1 Wall Street Analyst
Management's thesis regarding the spinoff is now being tested. 
Via The Motley Fool
Nearing Retirement? These Stocks Are as Cautious as They Come
Healthcare blue chips can provide retirees the consistency they need while growing their nest eggs further. 
Via The Motley Fool
7 Dividend Stocks Every Investor Should Own to Survive a Market Crash
Buying dividend stocks for retirement is an excellent way to protect your portfolio in the event of a recession or depression. 
Via InvestorPlace
Topics Economy Retirement
Exposures Economy Pension
5 Most Owned Dividend Aristocrats® by Top Hedge Funds
These five Dividend Aristocrats® all pay safe, reliable, growing dividends. 
Via The Motley Fool
3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition
Here are the three dividend stocks that will never disappoint you. Buy them while they trade at a discount. 
Via InvestorPlace
7 Stocks to Buy Now if You Think the S&P 500’s Winning Streak Will Continue
S&P 500 is hitting new highs and if you want to make the most of this, buy these S&P 500 stocks. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Pension Plan Redux: 3 Companies That Could Take a Page From IBM’s Playbook
A new wrinkle from IBM regarding its pension plans could save the company hundreds of millions in future defined contribution payments. 
Via InvestorPlace
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price. 
Via InvestorPlace
FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients
FDA greenlights Johnson & Johnson's Tecvayli for reduced dosing in multiple myeloma patients, achieving complete response for 6+ months. 
Via Benzinga
Exposures Product Safety
2 Beaten-Down Stocks to Buy and Hold for 10 Years
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles. 
Via The Motley Fool
Top 7 Contenders to Join the Trillion-Dollar Club
Microsoft's ascent to the $3 trillion mark highlights the growing influence of trillion-dollar companies in the stock market. 
Via InvestorPlace
5 Forever Dividend Stocks to Build Your Portfolio
These five stocks are high quality and reliable. 
Via The Motley Fool
Income Lover’s Paradise: 3 Dividend Stocks with Stellar Track Records
Over 60 years of annual dividend growth signals that these dividend stocks are quality companies with durable competitive advantages. 
Via InvestorPlace
The Smartest Dividend Stocks to Buy With $400 Right Now
These companies will build an ever-growing stream of passive income, one share at a time. 
Via The Motley Fool
Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul
AAPL, AB InBev, and Johnson & Johnson are some of the best blue-chip stocks to buy and hold to fortify your investment portfolio. 
Via InvestorPlace
If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today
Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good investment? 
Via The Motley Fool
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
96 97 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.